Dementia clinical trials
147 active trials name this condition. Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- Effects of Binaural Beats and Spatialized Music on Behavioural and Psychological Symptoms of Dementia in Assisted Living Facility Residents
- Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease
- Testing the Pain Clinical Practice Guideline
- Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA
- The Black Immigrant Project
- Activity Tracking, Care Partner Co-participation, Text Reminders, Instructional Education, Video-Guided Physical Rehabilitation, and Exercise
- Resilient Together for Dementia (RT-D)
- SHARE Adaptation Intervention for African-American Families
- Web-based Cognitive Behavioral Treatment for Insomnia in Dementia Caregivers
- Effects of Accelerated rTMS on Cognitive Function
- Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's
- Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
- Enhancing Language Function in Aphasia
- Early-Stage Partner in Care Living Alone Plus
- Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia
- Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia
- Remote tDCS and Chair Yoga for Chronic Knee Pain in Alzheimer's Patients
- A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
- Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Impact of a Biophoton Therapy on Patients With Brain Disorders
- Dementia and Diabetes Prevention Program
- Combating Alzheimer's Through Sleep and Exercise
- Sleep Enhancement for Older Adults Living With Memory Loss And Their Care Partners
- Enhancing Attention and Wellbeing Using Digital Therapeutics
- IMST for Dementia Risk Reduction
- Goal Setting to Promote Physical Activity Adherence in Midlife Adults
- Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- Cognitive Screening Made Easy for PCPs - Administrative Supplement
- Assess Fibrin in Brains With AD/ADRD
- Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
- Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
- Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
- PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
- Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia
- Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
- Paradoxical Lucidity in Severe End-Stage Dementia
- Investigations of Dementia in Parkinson Disease
- Genetic Characterization of Movement Disorders and Dementias
- Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies
- Alzheimer's Disease Genetics Study
- Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
- ADRC Clinical Cohort (Alzheimer's Disease)
- Study to Understand Novel Biomarkers in Researching Dementia
- Delirium Identification in Older Patients With Alzheimer's and Other Related Dementias In the Emergency Department
- Genetic Studies of Early-onset Dementia
- OCT Angiography and NRAI in Dementia
- Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
- F 18 T807 Tau PET Imaging of Alzheimer's Disease
- 100-Year Human Aging Study
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Dementia” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.